Saturday July 04 2009 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
BioNews - BioPortfolio's News Portal
New Drug Applications IND Headlines
Sign-up to BioPortfolio's
New Drug Application IND news alerts
.
Subscribe to
BioWatch News Email alerts
-
open
BioWatch PDF brochure
.
Publish your news
using BioNewsCast
- open
BioNewsCast PDF brochure
.
Teva Pharmaceutical Industries Ltd declares launch of Tri-Lo Sprintec tablets
TradingMarkets:
similar ...
Teva wins FDA approval for generic oral contraceptive
TradingMarkets:
similar ...
Will Regulated Product Submission (RPS) Trump eCTD?
eCliniqua:
similar ...
Will Regulated Product Submission (RPS) Trump eCTD?
Bio-IT World:
similar ...
DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
Pharma Live:
similar ...
Cytopia Files Application for New Myelofibrosis Inhibitor
Pharmaceutical Technology:
similar ...
Cytopia Lodges IND for JAK2 Inhibitor CYT387
Pharma Live:
similar ...
Cytopia Limited (CYT.AX) Lodges IND for JAK2 Inhibitor CYT387
BioSpace:
similar ...
Cytopia Lodges IND for JAK2 Inhibitor CYT387
Montana's News Station:
similar ...
Cytopia Lodges IND for JAK2 Inhibitor CYT387
KLFY:
similar ...
Cytopia Lodges IND for JAK2 Inhibitor CYT387
KOTA Territory News:
similar ...
Cytopia Lodges IND for JAK2 Inhibitor CYT387
KSLA:
similar ...
Cytopia Lodges IND For JAK2 Inhibitor CYT387
Pharmaceutical Online:
similar ...
Families Of Spinal Muscular Atrophy Announces Latest Developments On Three SMA Drug Discovery Programs
MediLexicon:
similar ...
Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs
Montana's News Station:
similar ...
Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs
KLFY:
similar ...
Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs
NewsBlaze:
similar ...
DURECT Corporation (DRRX) Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President,
BioSpace:
similar ...
DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
Pharmacy Choice:
similar ...
DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
KSLA:
similar ...
